DVA: DaVita Inc Forward P/S Multiple

davita.com - graphic logo of issuer DVA

DaVita Inc. (DVA) is implementing eco-friendly water conservation technologies and transitioning to clean energy across its centers. The change in forward P/S on the GURU.Markets aggregate chart shows that the metric has reached 0.70, confirming the business's status as a defensive asset with guaranteed demand. To reduce energy costs, DaVita Inc. (DVA) is optimizing wastewater filtration and procuring renewable energy sources.

DVA (davita.com) Forward Price to Sales history from 07/04/2022 to 11/15/2026

DaVita Inc. - analytical breakdowns and key metrics (DVA)

- stock price and consensus target price:
- market capitalization information:
Analysis of all company metrics:DaVita Corp (DVA)
Original product of DaVita Corp

Forward P/S compares current market capitalization with expected revenue, allowing for a valuation of the business relative to future sales flows. The ratio is sensitive to revenue forecasts; therefore, the forward P/S dynamics of DaVita Inc. (DVA) help filter out one-off market noise and identify the real valuation trend. For DaVita Inc. (DVA), this indicator is critical as it reflects the business's resilience to inflationary pressure on the cost of medications and consumables.

Analysis of competing companies

Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple RDNT|OPCH: Forward Price to Sales|Forward Price-to-Revenue Multiple SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Forward Price to Sales|National Vision - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Progyny Inc (PGNY)|Ardent Health - Forward P/S Multiple|Market Cap to Expected Sales Ratio Select Medical Corp SEM|ASTH: Forward P/S Multiple|Market Cap to Projected Revenue MD|USPH (US Physical Therapy Inc) - Forward P/S Multiple|PNTG: Forward Price to Sales|Price-to-Projected Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Forward Price to Sales|Forward P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Market Cap to Future Revenue Ratio|EOLS - Price-to-Projected Revenue Ratio|Forward Price to Sales CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue MDWD|Price-to-Projected Revenue Ratio biote Corp.|Market Cap to Future Revenue Ratio thejoint.com JYNT|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple P3 Health PIII|Forward P/S Multiple GANX (Gain Therapeutics Inc.)|Forward P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - Forward P/S Multiple|CLGN: Price-to-Projected Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Concord Medical|AMS (American Shared Hospital Services Inc) - Forward P/S Multiple|MEDIROM Corp (MRM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ALBT|Market Cap to Expected Sales Ratio DIH Holding|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)